BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27037013)

  • 1. Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new.
    Sato M; Ohtsuka M; Watanabe S; Gurumurthy CB
    Biol Direct; 2016 Mar; 11(1):16. PubMed ID: 27037013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo genome editing targeted towards the female reproductive system.
    Sato M; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S; Gurumurthy CB
    Arch Pharm Res; 2018 Sep; 41(9):898-910. PubMed ID: 29974342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Production of Genome-Edited Rats.
    Sato M; Nakamura S; Inada E; Takabayashi S
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GONAD: A Novel CRISPR/Cas9 Genome Editing Method that Does Not Require Ex Vivo Handling of Embryos.
    Gurumurthy CB; Takahashi G; Wada K; Miura H; Sato M; Ohtsuka M
    Curr Protoc Hum Genet; 2016 Jan; 88():15.8.1-15.8.12. PubMed ID: 26724720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental competence of porcine genome-edited zygotes.
    Gil MA; Martinez CA; Nohalez A; Parrilla I; Roca J; Wu J; Ross PJ; Cuello C; Izpisua JC; Martinez EA
    Mol Reprod Dev; 2017 Sep; 84(9):814-821. PubMed ID: 28471514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing.
    Hashimoto M; Takemoto T
    Sci Rep; 2015 Jun; 5():11315. PubMed ID: 26066060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation.
    Qin W; Wang H
    Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins.
    Ménoret S; De Cian A; Tesson L; Remy S; Usal C; Boulé JB; Boix C; Fontanière S; Crénéguy A; Nguyen TH; Brusselle L; Thinard R; Gauguier D; Concordet JP; Cherifi Y; Fraichard A; Giovannangeli C; Anegon I
    Sci Rep; 2015 Oct; 5():14410. PubMed ID: 26442875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.
    Cottle RN; Lee CM; Archer D; Bao G
    Sci Rep; 2015 Nov; 5():16031. PubMed ID: 26558999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation-Mediated CRISPR/Cas9 Genome Editing in Rat Zygotes.
    Davis DJ; Men H; Bryda EC
    Methods Mol Biol; 2023; 2631():267-276. PubMed ID: 36995672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful
    Takabayashi S; Iijima K; Tsujimura M; Aoshima T; Takagi H; Aoto K; Sato M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential i-GONAD: An Improved In Vivo Technique for CRISPR/Cas9-Based Genetic Manipulations in Mice.
    Sato M; Miyagasako R; Takabayashi S; Ohtsuka M; Hatada I; Horii T
    Cells; 2020 Feb; 9(3):. PubMed ID: 32110989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CRISPR/Cas9 and gene therapy].
    Giono LE
    Medicina (B Aires); 2017; 77(5):405-409. PubMed ID: 29044017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots.
    Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W
    PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GONAD: Genome-editing via Oviductal Nucleic Acids Delivery system: a novel microinjection independent genome engineering method in mice.
    Takahashi G; Gurumurthy CB; Wada K; Miura H; Sato M; Ohtsuka M
    Sci Rep; 2015 Jun; 5():11406. PubMed ID: 26096991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient production of biallelic GGTA1 knockout pigs by cytoplasmic microinjection of CRISPR/Cas9 into zygotes.
    Petersen B; Frenzel A; Lucas-Hahn A; Herrmann D; Hassel P; Klein S; Ziegler M; Hadeler KG; Niemann H
    Xenotransplantation; 2016 Sep; 23(5):338-46. PubMed ID: 27610605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Genome Editing via Oviductal Nucleic Acids Delivery (i-GONAD): Protocol Steps and Additional Notes.
    Sato M; Nakamura A; Sekiguchi M; Matsuwaki T; Miura H; Gurumurthy CB; Kakuta S; Ohtsuka M
    Methods Mol Biol; 2023; 2631():325-340. PubMed ID: 36995675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of CRISPR/Cas9-related mRNA microinjection after activation as an important factor affecting genome editing efficiency in porcine oocytes.
    Sato M; Kosuke M; Koriyama M; Inada E; Saitoh I; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S; Miyoshi K
    Theriogenology; 2018 Mar; 108():29-38. PubMed ID: 29195121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.